Introduction
Since children with newly diagnosed type 1 diabetes (T1DM) can present a mild clinical picture or alternatively diabetic ketoacidosis (DKA), the hormonal pattern in response to metabolic stress may be various. The variations in hormone levels usually correlate with the severity of the metabolic derangement [1, 2] , with the adrenal and the thyroid function being the most involved. The adrenal is classically overstimulated, while the hypothalamus-pituitary-thyroid axis shows a variable impairment defined as nonthyroidal illness syndrome (NTIS) [3] [4] [5] [6] . A relationship between the degree of NTIS and severity of metabolic derangement has been previously described in adult and pediatric patients [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Moreover, thyroid autoimmunity may be impaired in diabetic patients and could further affect the hypothalamus-pituitary-thyroid axis. Among children and adolescent with newly diagnosed T1DM, in fact, the presence of positive antibody titers varies from 6 to 16 % in the various case series [18, 19] .
To our knowledge, no other studies have investigated both thyroid and adrenal functions at T1DM onset in a pediatric population; furthermore, there are few longitudinal studies on pediatric patients on the evolution of thyroid
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To investigate the correlation between hormonal pattern and DKA at T1DM onset and the influence of autoimmunity on thyroid function at onset and during follow-up, we performed in 152 children and adolescents a cross-sectional evaluation of thyroid and adrenal hormone pattern at T1DM onset and a longitudinal study of thyroid function and autoimmunity during the following years.
Subjects and methods

Subjects
Between January 2000 and August 2012, 152 children and adolescents (76 males and 76 females) were consecutively diagnosed with T1DM. They represented 100 % of the patients diagnosed with T1DM in our center during that period fulfilling the inclusion criteria. Inclusion criteria were: T1DM at onset and age at onset less than 16 years. Exclusion criteria were the presence of known thyroid, adrenal or autoimmune diseases. The median age at T1DM onset was 7.7 ± 4 years (range 0.9 ± 15.5) and 114 patients (75 %) were prepubertal. Clinical presentation was as follows: 9 patients were asymptomatic, 101 had mild symptoms such as polyuria and polydipsia, 34 showed more severe symptoms like dehydration and Kussmaul breathing and 8 patients had an impaired consciousness or coma. Five patients were diagnosed with celiac disease at diabetes onset and consequently started a gluten-free diet.
At T1DM onset, the patients were divided according to the presence of positive (group 1, n.18, 11.6 %) or negative antithyroid antibody titers (group 2, n.134). In each group, the patients were arbitrarily subdivided according to thyroid function impairment into four subgroups: normal (a), hyperthyreotropinemia (TSH levels between 5 and 10 µUI/ ml with normal FT3 and FT4 values) (b), low FT3 levels (c) and low FT3 and FT4 levels with low/normal TSH levels (d).
Seventy-eight short normal children matched by age and sex with diabetic patients were evaluated as the control group.
Methods
At each examination, the height was measured with a Harpenden stadiometer (mean of 3 measurements) and the nutritional status was evaluated through weight and BMI.
At diagnosis, the following biochemical parameters were evaluated: glucose, glycosylated hemoglobin (HbA1c), fructosamine, base excess (BE), pH, electrolytes, basal C-peptide, white blood cells, TSH, free T3, free T4, thyroperoxidase and thyroglobulin antibodies, ACTH, cortisol, aldosterone and renin activity levels.
Not all parameters were evaluated for all patients. After T1DM onset, biochemical assessment of thyroid function was performed almost yearly in all patients. Whole mean follow-up was 5.45 ± 2.8 years (range 1.5-13.1) and was available in 113 patients (74.3 %). Fifteen belonged to group 1 and 98 to group 2.
The electrochemiluminescence (ECLIA) method was used for measuring FT3, FT4, TSH, thyroperoxidase (TPO Ab) and thyroglobulin antibodies (TG Ab), C-peptide and cortisol (after extraction). The reference ranges are: FT3 2.9-6.8 pg/ml for patients younger than 1 year, 2.5-5.5 pg/ ml for patient from 1 to 12 years old, 2.4-5 pg/ml for older than 12 years, FT4 9-17 pg/ml, TSH 0.27-4.2 μUI/ml, C-peptide 1.1-4.4 ng/ml and cortisol 62-194 ng/ml. To compare the data during a long-term follow-up, antithyroid antibody positivity was defined as titer increase >50 % above upper normal limit for our laboratory in the period considered. Levothyroxine was prescribed when TSH levels were found to be more than 8 μUI/ml in two consecutive evaluations and with the presence of antibodies, even with the absence of low FT4 levels (subclinical hypothyroidism). In particular, levothyroxine was started in four cases with TSH levels higher than 10 μUI/ml in at least two determinations and in one patient with persistent TSH levels between 8 and 10 μUI/ml and decreasing free fractions, even if in the normal range.
The immunochemiluminometric (ICMA) assay was used for ACTH (normal range 5-60 pg/ml), and the radioimmunoassay method was used for aldosterone (normal range 80-300 pg/ml in orthostatism and 30-100 pg/ml in supine position) and renin activity (normal range 1.9-3.9 ng/ml/h in orthostatism and 0.2-2.2 ng/ml/h in supine position). HbA1c levels were measured by HPLC with Auto A1c TM Analyzer HA 8110 (Kyoto Daiichi, Kagaku, Japan); the normal range was 20-42 mmol/mol in ICFF units (as 4.3-5.9 % in NPSG/DCCT units). Fructosamine was measured by the NBT method and the normal range was 205-285 μmol/l. The flow cytofluorimetric analysis was used for white blood cell (normal range 4.2-9.0 × 10 independent samples, while skewed distributions were compared using Mann-Whitney test. Normality of distribution was tested calculating skewness and kurtosis values. Correlation analysis was performed and the Pearson correlation coefficient r was assessed for parametric data, while Spearman correlation coefficient was assessed in case of nonparametric data. Chi-square test was performed to compare prevalence in different populations. ANOVA analysis was used to study the variance between the subgroups of patients and, as for the latter analysis, we considered a statistical significance less than or equal to 0.008 after correction by Bonferroni post hoc test. Multiple regression analysis was performed and predictors were considered regarding the correlation's significance.
Results
Onset of T1DM Table 1 shows the distribution of patients according to the different thyroid function impairment in groups 1 and 2. There were no significant differences between the two groups and therefore patients were considered as a whole group in the following analysis. Table 2 shows the clinical and metabolic features in diabetic patients subdivided according to normal or abnormal thyroid pattern at onset. Patients with abnormal thyroid function showed a deeper metabolic derangement compared to those with normal thyroid function.
A further analysis of the four subgroups is reported in Table 3 . We compared diabetic patients with normal thyroid function with the remaining patients subdivided according to the different degrees of thyroid impairment. The patients of subgroups c and d, presenting a deeper thyroid function impairment, showed metabolic parameters significantly worse than the patients of subgroup a. Patients -peptide (ng/ml) 0.7 ± 0.5 0.5 ± 0.2 0.5 ± 0.3°°0.4 ± 0.4°°° with hyperthyreotropinemia showed no significant differences compared to patients with normal thyroid function. Finally, we compared the thyroid hormone values of diabetic patients with normal thyroid function (subgroup a) with those of control group subjects ( Table 4 ). As shown in Table 4 , this subgroup of patients with T1DM, despite showing normal thyroid function, presented significantly lower FT3 and FT3/FT4 ratio compared to the control group.
Thyroid ultrasound was performed in 18/20 patients (90 %) with thyroid autoimmunity and in 15/18 of cases (83 %) a nonhomogeneous pattern consistent with lymphocytic thyroiditis was identified, whereas in the remaining 17 % ultrasound revealed a normal gland.
Follow-up
Examination after 18 months
In group 1, ten patients (66 %) showed persisting positive antibody titers with normal thyroid function and two patients (13 %) with normal thyroid function at diabetes onset developed subclinical hypothyroidism and started replacement therapy, whereas three patients became negative for thyroid antibody titers. In group 2, four patients developed positive antibody titers associated with normal thyroid function and no patients required replacement therapy. NTIS abnormalities disappeared in all patients of both groups.
Whole follow-up
On considering the last examination, 8/15 of the patients of group 1 showed persisting positive antibody titers with normal thyroid function, 3/15 patients showed subclinical hypothyroidism and started replacement therapy and 4/15 patients became negative for thyroid antibody titers. In group 2, 8/98 patients developed persisting positive antibody titers, in six cases associated with normal thyroid function and in two cases (2 %) with subclinical hypothyroidism requiring replacement therapy, while three patients showed a transient hyperthyreotropinemia without antithyroid antibodies. The prevalence of subclinical hypothyroidism was significantly higher during short-term and long-term follow-up in group 1 than in group 2 (after 18 months 2/15 vs 0/98 p < 0.01, at the end of follow-up 3/15 vs 2/98 p < 0.05).
Among patients presenting with T1DM and celiac disease, two patients showed positive antithyroid antibody titers (1 patient from the onset and 1 patient during followup) with normal thyroid function.
Correlations and multiple regression analysis
The variables included in the analysis were base excess, renin activity, aldosterone, C-peptide, age at diabetes onset, white blood cell, cortisol, glycemia, pH, sodium, FT3, FT4 and TSH. In multiple regression analysis, the only variable showing correlation with FT3 was base excess (R 2 = 0.98, p < 0.005), while C-peptide and age at diabetes onset showed a strong correlation with FT4 (R 2 = 0.98, p < 0.0001). TSH was not correlated with any of the variables studied.
Discussion
In our pediatric patients, positive antithyroid antibody titer was found in 11.6 % of the cases at T1DM onset, in accordance with the percentage reported in previous studies [18, [21] [22] [23] . A recent meta-analysis by Shun et al. [20] on thyroid function during type 1 diabetes found a highly variable incidence of thyroid dysfunction, from 27 to 246 per 10,000 patients/years, while thyroid autoimmunity ranged from 13 to 326 per 10,000 patients/years.
The prevalence of NTIS and the degree of NTIS abnormalities were not influenced by the presence of these positive titers at onset of diabetes. The severity of the impairment of pituitary-thyroid axis seems therefore to be related to the degree of metabolic derangement irrespective of the presence-absence of antithyroid antibodies. However, patients with antithyroid antibodies at T1DM onset showed higher risk to develop hypothyroidism over time and consequently to require replacement therapy. NTIS is a condition well described in literature in patients with severe acute illness recovering in ICU or in patients with anorexia nervosa, where it may affect 60-70 % of the cases. The illness severity has been found related to the degree of NTIS in many studies; therefore, a prognostic role has been suggested for this syndrome [3] [4] [5] [6] [24] [25] [26] [27] [28] [29] . The majority of the authors suggested that NTIS was an adaptive response to stress, reducing excessive energy expenditure for which replacement therapy was not required [5, 24, [30] [31] [32] . Otherwise, there is still debate on whether the most severe type of NTIS, with complete depression of hypothalamus-pituitary-thyroid axis, could be a maladaptive process and consequently whether hormone therapy should be needed [30] . In a recent review, Greet Van Den Berghe speculated that there may be a difference between short-term and longterm phases of critical illnesses: initially, in fact, NTIS could be partly due to macronutrient deficiency and therefore adaptive against catabolism, whereas, if the disease is severe and prolonged, a replacement therapy may be helpful because of the negative impact of thyroid suppression on the final outcome [33] . Diabetes onset is a condition potentially critical when associated with severe DKA and a relationship between bad metabolic control of diabetes and NTIS has been described since 1976 [7] . However, most of the previous studies examined adult patients with an already diagnosed type 1 or type 2 diabetes affected by a serious metabolic derangement or ketoacidosis [8] [9] [10] [11] . There are very few studies examining thyroid function at diabetes onset in the pediatric population, of which many are related to thyroid autoimmunity [18, 21, 22] .
The first manuscript by Gilani et al. concerning NTIS at T1DM diagnosis in children is dated 1984 [19] : in that study, 56 antithyroid antibodies-negative children with newly diagnosed T1DM showed significantly lower levels of T3, T4 and FT4 compared to healthy controls. Moreover, a negative correlation between thyroid function and glucose metabolism and a positive correlation with metabolic balance were found. All thyroid abnormalities disappeared after the administration of insulin. More recently, Lin et al. evaluated thyroid function in 138 newly diagnosed children with T1DM, subdivided into two groups according to the presence of DKA at onset. The DKA group showed more pronounced abnormalities for the whole thyroid pattern (T3, T4, FT4), whereas the non-DKA group showed only T3 levels significantly lower than controls [2] . Our data confirmed these findings. In fact, diabetic patients with normal thyroid function at T1DM onset had a less severe insulin deficiency demonstrated by higher C-peptide levels. Therefore they were less stressed, with a milder metabolic acidosis and a lower activation of the adrenal gland. On the contrary, the group of patients with the most severe impairment of pituitary-thyroid axis showed a more pronounced metabolic stress due to a severe insulin deficiency compared to the other groups, with lower pH and BMI SDS and higher cortisol levels. We should point out that the mean age of the patients in this group was significantly lower than in the other groups. It is likely that younger children may less tolerate insulin deficiency and hyperglycemia and, hence, present a more important metabolic acidosis and a deeper impairment of thyroid function, irrespective of the residual beta cell function. In fact, they showed lower C-peptide levels than patients with normal thyroid function, but similar to patients with low FT3 levels.
In our case series, the prevalence of patients with hyperthyreotropinemia was similar in patients with or without thyroid autoantibodies. As for glucose metabolism and acid-base balance, this group of patient resembled those with normal thyroid function, since they both presented no hypothalamus-pituitary axis alterations and no differences in parameters of metabolic stress (Table 3 ). These data suggest that hyperthyreotropinemia is a result of the physiological response of the hypothalamus-pituitarythyroid axis, similar to that in nondiabetic patients during other acute diseases [34] . After the administration of insulin, NTIS abnormalities normalized spontaneously in all patients, also in the group with the most severe depression of the pituitary-thyroid axis. This pattern suggests that at T1DM onset, NTIS is adaptive and therefore does not require replacement therapy. In fact, the well-defined pathogenesis of DKA does not involve thyroid; consequently, thyroid function is impaired by metabolic acidosis and not vice versa. Finally, we must emphasize that, in agreement with our previous observations [14] , the reduced conversion from FT4 to FT3 even in diabetic children with normal thyroid function (subgroup a, Table 2 ) compared to controls may be considered a process of adaptation of the peripheral metabolism of thyroid hormones.
Regarding autoimmunity, thyroid function at T1DM onset could be impaired because of autoimmune thyroid diseases, the prevalence of which is higher in these patients. In fact, in children and adolescents with newly diagnosed T1DM, positive antibody titers were found with varying frequencies, from 6 to 16 %, while hypothyroidism was reported less frequently [18] . Machnica et al. described a frequency of 12.6 % of thyroid antibodies in children at diabetes onset. They compared children with positive antibodies titer at onset with the remaining group of children without antibodies and found no significant differences except for age at T1DM onset (patients with antithyroid antibodies were older, p < 0.05), regarding anthropometric parameters, glucose metabolism, lipid profile, metabolic balance and thyroid function [21] . Gonzalez et al. described a slightly higher prevalence of antithyroid antibodies at diabetes onset (14.2 %) and followed this population for a median period of 9.6 ± 4.3 years. At the end of follow-up, they reported a higher prevalence of thyroid dysfunction in patients with positive antibodies titer at diabetes onset. In consideration of the high sensitivity and specificity of antibodies present at onset as marker of future thyroid dysfunction, they suggested the annual determination of thyroid function in subjects with positive antibodies [22] . Glastras et al. reported similar findings [18] . More recently Joseph et al. examined 110 children at diabetes onset and during a period of followup of 2.3 years. Thyroid dysfunctions were found in 19 % of patients at diabetes diagnosis and were significantly more frequent in patients with DKA [35] . Furthermore, in this study T3 and FT3 were not measured and consequently they discovered only the most severe cases of NTIS, characterized by suppression of TSH and/or FT4. Moreover, they did not evaluate thyroid autoimmunity at T1DM onset in all patients, but only those with persistent abnormalities. Finally, these authors suggested not performing thyroid biochemical assessment in clinically euthyroid patients at T1DM onset, because of the high prevalence of thyroid abnormalities wholly associated with metabolic derangement. Our results are in agreement with Glastras and Gonzalez's studies: in our cohort; in fact, the presence of antithyroid antibodies at diabetes onset resulted in a significantly higher risk of developing hypothyroidism with the need to start replacement therapy during follow-up. We suggest therefore that the screening for antithyroid antibodies at T1DM onset is useful to identify which patients require a tighter control of thyroid function during follow-up. A limitation of our study is the lack of complete data about thyroid ultrasound, since we did not perform the examination in patients without circulating autoantibodies and therefore we may have underestimated the percentage of patients with thyroiditis.
Conclusions
We confirm that at T1DM onset, thyroid function is impaired mainly in association with metabolic stress, without the influence of thyroid autoimmunity. Nonthyroidal illness syndrome, present in half of our patients, recovered spontaneously with normalization of DKA, leaving no sequelae. Since hypothyroidism developed more frequently in patients with antithyroid antibodies at onset, we suggest that thyroid autoimmunity should be examined at the onset of T1DM to identify patients at risk of developing hypothyroidism.
